Moppett J, Burke G A A, Steward C G, Oakhill A, Goulden N J
Department of Paediatric Oncology and Haematology, Bristol Royal Hospital for Children, Bristol BS2 8JD, UK.
J Clin Pathol. 2003 Apr;56(4):249-53. doi: 10.1136/jcp.56.4.249.
Risk directed treatment forms a central component of modern protocols for childhood acute lymphoblastic leukaemia (ALL). A review of recent studies of minimal residual disease (MRD) analysis shows that it is a powerful prognostic factor in both first line and relapse treatment. However, the value of MRD analysis is both time point and protocol specific, and the threshold for MRD detection of the technique used impacts upon the results obtained. MRD analysis does have a useful role to play in the risk directed treatment of childhood ALL, and this is currently being investigated in large prospective studies.
风险导向治疗是现代儿童急性淋巴细胞白血病（ALL）治疗方案的核心组成部分。对近期微小残留病（MRD）分析研究的综述表明，它在一线治疗和复发治疗中都是一个强大的预后因素。然而，MRD分析的价值既取决于时间点，也因方案而异，所使用技术的MRD检测阈值会影响所得结果。MRD分析在儿童ALL的风险导向治疗中确实具有重要作用，目前大型前瞻性研究正在对此进行调查。
Zotero 插件